Epidemiologic and Survival Trends in Amyloidosis, 1987-2019

An analysis of 11,006 patients in the U.K. showed that the incidence of amyloidosis increased from 1967 to 2019. Light-chain amyloidosis was the most common type and accounted for 56% of all cases. With the introduction of new agents, overall survival has increased, but early mortality has not declined.